Tekmira shares surge after Thomas Duncan's death announced.
In an ongoing phase II study, ARC-520 dosed at 2 mg/kg induced a 0.3 log reduction in HBsAG, a measure of the presence of hepatitis B virus in the body.
If Northwest Bio's cancer vaccines -- DCVax-L and DCVax Direct -- are so promising, hedge funds should be falling over themselves to own the stock, not short it.
For the past three months, small-cap biotech stocks have been underperforming the broader market.
Treatment with an experimental formulation of vitamin B6 known as MDX failed to improve the symptoms of attention-deficit hyperactivity disorder compared to placebo.
Sunesis' experimental drug vosaroxin did not extend survival of elderly patients with advanced acute myeloid leukemia compared to a placebo.
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.
Martin is super smart and will be a great asset somewhere, but he is not a CEO. I wish him the best.
What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?